Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist

[Pyr(1)]apelin-13 is an endogenous vasodilator and inotrope but is downregulated in pulmonary hypertension and heart failure, making the apelin receptor an attractive therapeutic target. Agonists acting at the same G-protein-coupled receptor can be engineered to stabilize different conformational st...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Hypertension (Dallas, Tex. 1979) Ročník 65; číslo 4; s. 834
Hlavní autoři:	Brame, Aimee L, Maguire, Janet J, Yang, Peiran, Dyson, Alex, Torella, Rubben, Cheriyan, Joseph, Singer, Mervyn, Glen, Robert C, Wilkinson, Ian B, Davenport, Anthony P
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.04.2015
Témata:	Animals Antipyretics Apelin Receptors Disease Models, Animal GTP-Binding Proteins - metabolism Humans Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - metabolism Hypertension, Pulmonary - physiopathology Intercellular Signaling Peptides and Proteins - pharmacology Male Rats Rats, Wistar Receptors, G-Protein-Coupled - agonists Receptors, G-Protein-Coupled - metabolism Research Design Saphenous Vein - drug effects Saphenous Vein - metabolism Saphenous Vein - physiopathology Vasodilation - drug effects pulmonary arterial hypertension [Pyr1]apelin-13 β-arrestin G-protein coupled receptors
ISSN:	1524-4563, 1524-4563
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!